Remacemide is a low-affinity NMDA receptor antagonist that also exhibits sodium channel blocking activity. It has been investigated in preclinical and clinical research for neurological conditions including epilepsy, Parkinsons disease, Huntingtons disease, and acute ischemic stroke.
Molekulargewicht:
268.35
CAS Nummer:
[128298-28-2]
Formel:
C17H20N2O
Target-Kategorie:
Others,iGluR
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten